SICK logo

SICKDS Dly Hlthr Br ETF

$0.00
$0.00
(0.00%)
Today
Updated:
News
all
press releases
News Placeholder
Eli Lilly Raises Full-Year Guidance By Whopping $3 Billion, Draws Retail Cheer
The major highlight of the pharmaceutical giant’s earnings came in the form of an increase in its full-year guidance by $3 billion to the range of $45.40 billion to $46.60 billion. The upgraded outlook was primarily driven by the strong performance of Mounjaro and Zepbound, as well as the firm’s non-incretin medicines.
Stocktwits
<
...
1
>
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.